Christian Lehmann

14PUBLICATIONS
82CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 07, 2025
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma.

Athanasios Seretis, Lukas Amon, Christoph H Tripp

|Aug 25, 2023
BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

Liwei Zhao, Peng Liu, Misha Mao

|Aug 11, 2023
XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors.

Lukas Heger, Lukas Hatscher, Chunguang Liang

|Dec 23, 2022
Guidelines for mouse and human DC functional assays.

Björn E Clausen, Lukas Amon, Ronald A Backer

|Apr 28, 2021
Select hyperactivating NLRP3 ligands enhance the T<sub>H</sub>1- and T<sub>H</sub>17-inducing potential of human type 2 conventional dendritic cells.

Lukas Hatscher, Christian H K Lehmann, Ariawan Purbojo

|Jan 20, 2021
Environmental signals rather than layered ontogeny imprint the function of type 2 conventional dendritic cells in young and adult mice.

Nikos E Papaioannou, Natallia Salei, Stephan Rambichler

Pageof 3

Frequent Collaborators

9 joint publications

Diana Dudziak

4 joint publications

Lukas Heger

3 joint publications

Lukas Amon

2 joint publications

Robert Cesnjevar